List of Tables
    Table 1. Smart Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Smart Drugs Market Trends
    Table 3. Smart Drugs Market Drivers
    Table 4. Smart Drugs Market Challenges
    Table 5. Smart Drugs Market Restraints
    Table 6. Global Smart Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Smart Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Smart Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Smart Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Smart Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Smart Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Smart Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Smart Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Smart Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Smart Drugs Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Smart Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Smart Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Smart Drugs as of 2021)
    Table 18. Top Players of Smart Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Smart Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Smart Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Smart Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Smart Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Smart Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Smart Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Smart Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Smart Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Smart Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Smart Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Smart Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Smart Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Smart Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Smart Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Smart Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Smart Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Smart Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Smart Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Smart Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Smart Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Smart Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Smart Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Nootrobox Corporation Information
    Table 43. Nootrobox Description and Business Overview
    Table 44. Nootrobox Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Nootrobox Smart Drugs Product
    Table 46. Nootrobox Recent Development
    Table 47. Cephalon Corporation Information
    Table 48. Cephalon Description and Business Overview
    Table 49. Cephalon Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Cephalon Product
    Table 51. Cephalon Recent Development
    Table 52. Purelife Bioscience Corporation Information
    Table 53. Purelife Bioscience Description and Business Overview
    Table 54. Purelife Bioscience Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Purelife Bioscience Product
    Table 56. Purelife Bioscience Recent Development
    Table 57. Peak Nootropics Corporation Information
    Table 58. Peak Nootropics Description and Business Overview
    Table 59. Peak Nootropics Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Peak Nootropics Product
    Table 61. Peak Nootropics Recent Development
    Table 62. Nootrico Corporation Information
    Table 63. Nootrico Description and Business Overview
    Table 64. Nootrico Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Nootrico Product
    Table 66. Nootrico Recent Development
    Table 67. SupNootropic Biological Technology Corporation Information
    Table 68. SupNootropic Biological Technology Description and Business Overview
    Table 69. SupNootropic Biological Technology Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. SupNootropic Biological Technology Product
    Table 71. SupNootropic Biological Technology Recent Development
    Table 72. AlternaScript Corporation Information
    Table 73. AlternaScript Description and Business Overview
    Table 74. AlternaScript Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. AlternaScript Product
    Table 76. AlternaScript Recent Development
    Table 77. Accelerated Intelligence Corporation Information
    Table 78. Accelerated Intelligence Description and Business Overview
    Table 79. Accelerated Intelligence Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Accelerated Intelligence Product
    Table 81. Accelerated Intelligence Recent Development
    Table 82. Onnit Labs Corporation Information
    Table 83. Onnit Labs Description and Business Overview
    Table 84. Onnit Labs Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Onnit Labs Product
    Table 86. Onnit Labs Recent Development
    Table 87. Powder City Corporation Information
    Table 88. Powder City Description and Business Overview
    Table 89. Powder City Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Powder City Product
    Table 91. Powder City Recent Development
    Table 92. Ceretropic Corporation Information
    Table 93. Ceretropic Description and Business Overview
    Table 94. Ceretropic Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Ceretropic Product
    Table 96. Ceretropic Recent Development
    Table 97. Nootropic Source Corporation Information
    Table 98. Nootropic Source Description and Business Overview
    Table 99. Nootropic Source Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Nootropic Source Product
    Table 101. Nootropic Source Recent Development
    Table 102. Clarity Nootropics Corporation Information
    Table 103. Clarity Nootropics Description and Business Overview
    Table 104. Clarity Nootropics Smart Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. Clarity Nootropics Product
    Table 106. Clarity Nootropics Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Smart Drugs Customers List
    Table 110. Smart Drugs Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Smart Drugs Product Picture
    Figure 2. Global Smart Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Smart Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Smart Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Smart Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Smart Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Smart Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Smart Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Smart Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Smart Drugs Report Years Considered
    Figure 11. Product Picture of Attention and Focus
    Figure 12. Product Picture of Memory Enhancement
    Figure 13. Product Picture of Mood and Depression
    Figure 14. Product Picture of Sleep and Anxiety
    Figure 15. Product Picture of Others
    Figure 16. Global Smart Drugs Market Share by Type in 2022 & 2028
    Figure 17. Global Smart Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Smart Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Smart Drugs Sales by Type (2017-2028) & (K Units)
    Figure 20. Global Smart Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Smart Drugs Price by Type (2017-2028) & (US$/Unit)
    Figure 22. United States Smart Drugs Market Share by Type in 2022 & 2028
    Figure 23. United States Smart Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Smart Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Smart Drugs Sales by Type (2017-2028) & (K Units)
    Figure 26. United States Smart Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Smart Drugs Price by Type (2017-2028) & (US$/Unit)
    Figure 28. Product Picture of Offline
    Figure 29. Product Picture of Online
    Figure 30. Global Smart Drugs Market Share by Application in 2022 & 2028
    Figure 31. Global Smart Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Smart Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Smart Drugs Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Smart Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Smart Drugs Price by Application (2017-2028) & (US$/Unit)
    Figure 36. United States Smart Drugs Market Share by Application in 2022 & 2028
    Figure 37. United States Smart Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Smart Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Smart Drugs Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Smart Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Smart Drugs Price by Application (2017-2028) & (US$/Unit)
    Figure 42. North America Smart Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Smart Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Smart Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe Smart Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Smart Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific Smart Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Smart Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 66. Latin America Smart Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Smart Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 71. Middle East & Africa Smart Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. UAE Smart Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Smart Drugs Value Chain
    Figure 76. Smart Drugs Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed